# CRDF (Cardiff Oncology, Inc.) - SEC EDGAR Financial Statements

> Cardiff Oncology, Inc. reported $559K in revenue and a net loss of $37.65M for the trailing twelve months ended September 30, 2026 (up 42.5% year over year), with a -7068.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/CRDF
- Markdown: https://convexityos.com/fundamentals/CRDF.md
- SEC CIK: 0001213037
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001213037&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $559K | +42.5% YoY |
| Operating Income | TTM | -$39.51M | -7068.2% margin |
| Net Income | TTM | -$37.65M | -6735.2% net margin |
| Diluted EPS | TTM | -$0.49 | Split-adjusted |
| Free Cash Flow | TTM | -$37.97M | -6791.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $33.79M | Total debt: $265K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $593K | $683K | $488K | $386K | $359K | $366K | $245K | $378K | $505K | $381K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $0 | $597K | $1.81M | $1.73M |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | $245K | -$219K | -$1.31M | -$1.35M |
| Research & Development | $35.33M | $36.85M | $32.86M | $27.10M | $17.40M | $11.24M | $11.16M | $8.16M | $7.88M | $15.01M |
| Selling, General & Admin | $14.22M | $12.48M | $13.04M | $13.18M | $11.84M | $8.22M | $5.76M | $8.01M | $14.23M | $23.00M |
| Total Operating Expenses | $49.55M | $49.33M | $45.90M | $40.29M | $29.21M | $19.45M | $16.92M | $17.43M | $26.10M | $40.53M |
| **Operating Income** | -$48.96M | -$48.65M | -$45.41M | -$39.90M | -$28.86M | -$19.09M | -$16.68M | -$17.05M | -$25.60M | -$40.15M |
| **EBITDA** | -$48.60M | -$48.25M | -$45.01M | -$39.67M | -$28.40M | -$18.62M | -$16.18M | -$16.19M | -$24.35M | -$39.08M |
| Interest Income | $3.10M | $3.26M | $4.07M | $1.58M | $264K | $90K | $234K | $219K | $148K | $299K |
| Interest Expense | -- | -- | -- | -- | $0 | $2.0K | $0 | $25K | $1.03M | $1.67M |
| Income Before Tax | -$45.85M | -$45.43M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$45.85M | -$45.43M | -$41.44M | -$38.70M | -$28.29M | -$19.31M | -$16.41M | -$16.46M | -$24.91M | -$39.20M |
| Basic EPS | -$0.69 | -$0.95 | -$0.93 | -$0.89 | -$0.73 | -$1.08 | -$2.80 | -$49.55 | -$310.50 | -$6,735.16 |
| **Diluted EPS** | -$0.69 | -$0.95 | -$0.93 | -$0.89 | -$0.73 | -$1.08 | -$2.80 | -$49.55 | -$310.50 | -$7,097.82 |
| Basic Shares Outstanding | 66.8M | 47.6M | 44.7M | 43.6M | 39.0M | 20.9M | 6.0M | 2.3M | 80.3K | 5.8K |
| Diluted Shares Outstanding | 66.8M | 47.6M | 44.7M | 43.6M | 39.0M | 20.9M | 6.0M | 388.4K | 80.3K | 5.8K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $171K | $104K | $41K | $243K | $120K | $121K | $109K | $151K |
| Research & Development | $5.03M | $5.92M | $6.76M | $5.08M | $8.20M | $11.58M | $10.48M | $9.71M |
| Selling, General & Admin | $4.36M | $3.80M | $6.13M | $3.00M | $3.90M | $3.32M | $4.01M | $3.01M |
| Total Operating Expenses | $9.39M | $9.72M | $12.89M | $8.07M | $12.09M | $14.90M | $14.49M | $12.72M |
| **Operating Income** | -$9.22M | -$9.62M | -$12.85M | -$7.83M | -$11.97M | -$14.78M | -$14.38M | -$12.57M |
| **EBITDA** | -$9.13M | -$9.53M | -$12.76M | -$7.74M | -$11.88M | -$14.68M | -$14.29M | -$12.48M |
| Interest Income | $363K | $382K | $506K | $612K | $716K | $835K | $941K | $787K |
| **Net Income** | -$8.86M | -$9.23M | -$12.35M | -$7.22M | -$11.26M | -$13.94M | -$13.43M | -$11.79M |
| Basic EPS | -$0.12 | -$0.14 | -$0.18 | -- | -$0.17 | -$0.21 | -$0.20 | -- |
| **Diluted EPS** | -$0.12 | -$0.14 | -$0.18 | -- | -$0.17 | -$0.21 | -$0.20 | -- |
| Basic Shares Outstanding | 76.2M | 68.4M | 68.3M | -- | 66.9M | 66.5M | 66.5M | -- |
| Diluted Shares Outstanding | 76.2M | 68.4M | 68.3M | -- | 66.9M | 66.5M | 66.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.47M | $51.47M | $21.66M | $16.35M | $11.94M | $131.0M | $10.20M | $11.45M | $8.23M | $13.92M |
| Short-Term Investments | $40.83M | $40.28M | $53.17M | $88.92M | $128.9M | $0 | -- | -- | $0 | $23.98M |
| **Cash & Short-Term Investments** | $58.30M | $91.70M | $74.80M | $105.3M | $140.8M | $131.0M | $10.20M | $11.45M | $8.23M | $37.89M |
| Accounts Receivable, Net | $182K | $773K | $288K | $771K | $535K | $320K | $203K | $168K | $77K | $100K |
| **Total Current Assets** | $60.13M | $95.05M | $77.41M | $111.3M | $146.1M | $133.4M | $11.35M | $12.77M | $9.47M | $38.95M |
| Property, Plant & Equipment, Net | $578K | $898K | $1.24M | $1.27M | $382K | $624K | $878K | $1.30M | $2.43M | $3.83M |
| Long-Term Investments | $8.89M | $6.27M | $26.86M | $5.00M | $33.29M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $549K | $69K | $1.28M | $1.39M | $239K | $404K | $158K | $103K | $390K | $1.17M |
| **Total Non-Current Assets** | $1.76M | $2.14M | $4.22M | $4.91M | $3.42M | $1.37M | $1.73M | $1.41M | $2.82M | $5.00M |
| **Total Assets** | $61.88M | $97.19M | $81.64M | $116.2M | $149.5M | $134.7M | $13.09M | $14.17M | $12.28M | $43.95M |
| Accounts Payable | $8.09M | $4.82M | $1.97M | $1.96M | $1.44M | $1.37M | $656K | $665K | $825K | $1.13M |
| Other Current Liabilities | -- | -- | -- | $0 | $42K | $42K | $0 | -- | -- | -- |
| **Total Current Liabilities** | $16.39M | $13.43M | $10.44M | $7.81M | $6.56M | $6.12M | $4.78M | $2.92M | $3.95M | $7.80M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $14.18M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $0 | $156K | $128K | $42K | -- | -- |
| **Total Non-Current Liabilities** | $102K | $813K | $1.46M | $2.04M | $2.57M | $450K | $993K | $1.16M | $1.83M | $16.39M |
| **Total Liabilities** | $16.50M | $14.24M | $11.90M | $9.85M | $9.13M | $6.57M | $5.78M | $4.09M | $5.78M | $24.18M |
| **Total Debt (incl. Leases)** | $832K | $1.52M | $2.15M | $2.71M | $3.12M | $869K | $1.73M | -- | $0 | $14.18M |
| Common Stock | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $8.3K | $7.7K | $5.3K | $3.1K |
| Retained Earnings | -$430.0M | -$384.2M | -$339.5M | -$298.1M | -$259.8M | -$231.5M | -$208.9M | -$192.2M | -$173.0M | -$148.1M |
| Accumulated Other Comp. Income | $50K | $34K | -$67K | -$395K | -$142K | $0 | -- | -- | $0 | -$11K |
| **Total Stockholders' Equity** | $45.39M | $82.95M | $69.74M | $106.3M | $140.4M | $128.2M | $7.31M | $10.08M | $6.51M | $19.77M |
| Total Equity | $45.39M | $82.95M | $69.74M | $106.3M | $140.4M | $128.2M | $7.31M | $10.08M | $6.51M | $19.77M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12.06M | $9.20M | $8.54M | $17.47M | $10.13M | $10.78M | $24.09M | $51.47M |
| Short-Term Investments | $21.73M | $25.32M | $37.51M | $40.83M | $50.46M | $60.17M | $55.79M | $40.28M |
| **Cash & Short-Term Investments** | $33.80M | $34.50M | $46.10M | $58.30M | $60.60M | $71.00M | $79.90M | $91.70M |
| Accounts Receivable, Net | $90K | $189K | $191K | $182K | $254K | $526K | $405K | $773K |
| **Total Current Assets** | $35.03M | $35.59M | $47.34M | $60.13M | $61.80M | $73.70M | $82.71M | $95.05M |
| Property, Plant & Equipment, Net | $364K | $450K | $491K | $578K | $666K | $666K | $805K | $898K |
| Long-Term Investments | $6.08M | $9.14M | $13.62M | $8.89M | $8.74M | $9.79M | $12.71M | $6.27M |
| Other Non-Current Assets | $799K | $927K | $844K | $549K | $549K | $401K | $257K | $69K |
| **Total Non-Current Assets** | $1.39M | $1.74M | $1.83M | $1.76M | $1.98M | $2.04M | $2.10M | $2.14M |
| **Total Assets** | $36.41M | $37.33M | $49.17M | $61.88M | $63.78M | $75.74M | $84.81M | $97.19M |
| Accounts Payable | $693K | $3.99M | $5.48M | $8.09M | $2.44M | $6.01M | $3.63M | $4.82M |
| **Total Current Liabilities** | $8.32M | $10.80M | $14.46M | $16.39M | $14.71M | $16.67M | $13.29M | $13.43M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $102K | $284K | $464K | $640K | $813K |
| **Total Liabilities** | $8.32M | $10.80M | $14.46M | $16.50M | $14.99M | $17.13M | $13.93M | $14.24M |
| **Total Debt (incl. Leases)** | $265K | $457K | $646K | $832K | $1.01M | $1.19M | $1.36M | $1.52M |
| Common Stock | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K |
| Retained Earnings | -$460.5M | -$451.6M | -$442.4M | -$430.0M | -$422.8M | -$411.6M | -$397.6M | -$384.2M |
| Accumulated Other Comp. Income | -$112K | -$62K | -$49K | $50K | $50K | $17K | $27K | $34K |
| **Total Stockholders' Equity** | $28.10M | $26.53M | $34.71M | $45.39M | $48.79M | $58.61M | $70.88M | $82.95M |
| Total Equity | $28.10M | $26.53M | $34.71M | $45.39M | $48.79M | $58.61M | $70.88M | $82.95M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.85M | -$45.43M | -$41.44M | -$38.70M | -$28.29M | -$19.31M | -$16.41M | -$16.46M | -$24.91M | -$39.20M |
| Depreciation & Amortization | $364K | $404K | $398K | $236K | $451K | $466K | $494K | $859K | $1.25M | $1.07M |
| Stock-Based Compensation | $5.69M | $4.76M | $4.51M | $4.26M | $3.23M | $1.76M | $885K | $2.17M | $4.01M | $7.50M |
| Change in Receivables | $591K | -$484K | $483K | -$236K | -$215K | -$117K | -$36K | $19K | $23K | -$1.7K |
| **Operating Cash Flow** | -$37.92M | -$37.69M | -$30.89M | -$33.82M | -$23.04M | -$16.32M | -$13.27M | -$13.20M | -$23.28M | -$31.04M |
| Capital Expenditure | -$44K | -$80K | -$582K | -$1.01M | -$205K | -$211K | -$68K | -$5.1K | -$101K | -$823K |
| **Free Cash Flow** | -$37.97M | -$37.77M | -$31.47M | -$34.83M | -$23.25M | -$16.53M | -$13.34M | -$13.20M | -$23.38M | -$31.86M |
| Purchases of Investments | -$71.86M | -$23.56M | -$70.08M | -$91.23M | -$174.4M | $0 | -- | -- | -- | -- |
| Sales & Maturities of Investments | $73.25M | $37.37M | $106.9M | $130.3M | $43.14M | $0 | -- | -- | -- | -- |
| **Investing Cash Flow** | $1.34M | $13.73M | $36.20M | $38.15M | -$131.4M | -$211K | -$68K | $23K | $23.96M | -$24.83M |
| Common Stock Issued | $0 | $53.41M | -- | $0 | $34.19M | $112.3M | $8.82M | $11.78M | $11.73M | $2.36M |
| **Financing Cash Flow** | $2.58M | $53.78M | $0 | $75K | $35.45M | $137.3M | $12.08M | $16.40M | -$6.38M | $2.30M |
| **Net Change in Cash** | -$34.00M | $29.82M | $5.31M | $4.40M | -$119.0M | $120.8M | -$1.26M | $3.23M | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.86M | -$9.23M | -$12.35M | -$7.22M | -$11.26M | -$13.94M | -$13.43M | -$11.79M |
| Depreciation & Amortization | $88K | $87K | $87K | $88K | $89K | $94K | $93K | $96K |
| Stock-Based Compensation | $1.34M | $920K | $1.66M | $1.26M | $1.38M | $1.68M | $1.36M | $1.20M |
| Change in Receivables | $99K | $2.0K | -$9.0K | $72K | $272K | -$121K | $368K | -$154K |
| **Operating Cash Flow** | -$9.87M | -$11.77M | -$12.29M | -$5.97M | -$10.83M | -$8.33M | -$12.79M | -$10.27M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$10.27M |
| Purchases of Investments | -$2.01M | -$1.30M | -$12.57M | -$6.72M | -$9.34M | -$19.98M | -$35.81M | $0 |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | -- | $4.51M |
| **Investing Cash Flow** | $3.61M | $12.27M | $3.26M | $10.75M | $10.16M | -$4.98M | -$14.58M | $4.51M |
| **Financing Cash Flow** | $9.13M | $149K | $105K | $2.55M | $25K | $0 | $3.0K | $44.19M |
| **Net Change in Cash** | $2.86M | $653K | -$8.93M | $7.33M | -$649K | -$13.31M | -$27.38M | $38.43M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | 100.0% | -57.9% | -258.4% | -354.1% |
| **Operating Margin** | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% | -5214.9% | -6817.8% | -4507.6% | -5064.4% | -10534.9% |
| **Net Profit Margin** | -7732.0% | -6651.7% | -8492.0% | -10026.9% | -7880.5% | -5275.2% | -6709.7% | -4351.1% | -4928.1% | -10287.7% |
| Return on Equity (ROE) | -101.0% | -54.8% | -59.4% | -36.4% | -20.1% | -15.1% | -224.5% | -163.2% | -382.8% | -198.3% |
| Return on Assets (ROA) | -74.1% | -46.7% | -50.8% | -33.3% | -18.9% | -14.3% | -125.4% | -116.1% | -202.7% | -89.2% |
| Current Ratio | 3.67x | 7.08x | 7.41x | 14.25x | 22.28x | 21.79x | 2.37x | 4.37x | 2.40x | 5.00x |
| Quick Ratio | 3.57x | 6.89x | 7.19x | 13.58x | 21.55x | 21.46x | 2.17x | 3.98x | 2.10x | 4.87x |
| Debt to Equity | 0.02x | 0.02x | 0.03x | 0.03x | 0.02x | 0.01x | 0.24x | -- | 0.00x | 0.72x |
| **Revenue Growth (YoY)** | -13.2% | +40.0% | +26.4% | +7.5% | -1.9% | +49.6% | -35.3% | -25.1% | +32.6% | +21.8% |
| 5Y Revenue / Share Growth | -49.4% | -65.0% | -93.3% | -99.9% | -100.0% | -100.0% | -99.9% | -99.8% | -96.5% | -52.4% |
| 10Y Revenue / Share Growth | -100.0% | -100.0% | -100.0% | -100.0% | -100.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -7068.2% | -8320.1% | -9033.9% | -8256.3% | -10719.6% | -9950.9% | -8860.5% | -7112.7% |
| **Net Profit Margin** | -6735.2% | -7884.1% | -8526.1% | -7732.0% | -10064.3% | -9344.1% | -8308.5% | -6642.0% |
| Return on Equity (ROE) | -134.0% | -151.0% | -129.0% | -101.0% | -103.3% | -87.1% | -68.9% | -54.8% |
| Return on Assets (ROA) | -103.4% | -107.3% | -91.0% | -74.1% | -79.1% | -67.4% | -57.6% | -46.7% |
| Current Ratio | 4.21x | 3.30x | 3.27x | 3.67x | 4.20x | 4.42x | 6.22x | 7.08x |
| Quick Ratio | 4.08x | 3.21x | 3.20x | 3.57x | 4.14x | 4.29x | 6.04x | 6.89x |
| Debt to Equity | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x |
| **Revenue Growth (YoY)** | +42.5% | -14.0% | -62.4% | +60.9% | -27.3% | -25.8% | -46.8% | -3.2% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
